PDSB - PDS Biotechnology GAAP EPS of -$0.35 beats by $0.10
2023-11-14 07:37:02 ET
More on PDS Biotechnology
- PDS Biotechnology: PDS0101 Being Put To The Test
- PDS Biotech reports encouraging survival data for HPV 16+ cancer therapy
- PDS Biotech posts Phase 1/2 data for prostate cancer therapy
- Seeking Alpha’s Quant Rating on PDS Biotechnology
- Historical earnings data for PDS Biotechnology
For further details see:
PDS Biotechnology GAAP EPS of -$0.35 beats by $0.10